HPR40 Determinants of FDA Review Duration for Novel Therapeutics: Analysis of Regulatory Designations and Product Characteristics
Abstract
Authors
Dmitriy Nikitin Shahariar Mohammed Fahim Foluso Agboola Marie Phillips Maria Lowe